CanniMed Therapeutics Inc (CMED.TO)
20 Apr 2018
Canada's No.2 marijuana producer Aurora Cannabis Inc on Wednesday received final regulatory approval for the purchase of smaller rival CanniMed Therapeutics Inc , which would make it the world's most valuable weed producer.
Feb 28 Canada's No.2 marijuana producer Aurora Cannabis Inc on Wednesday received final regulatory approval for the purchase of smaller rival CanniMed Therapeutics Inc, which would make it the world's most valuable weed producer.
BRIEF-Aurora Cannabis Announces Receipt Of Final Regulatory Approval For CanniMed Therapeutics Acquisition
* AURORA CANNABIS ANNOUNCES RECEIPT OF FINAL REGULATORY APPROVAL FOR CANNIMED THERAPEUTICS ACQUISITION AND ITS INTENTION TO TAKE-UP AS SOON AS MINIMUM TENDER CONDITION IS MET
BRIEF-Aurora Cannabis And Cannimed Therapeutics File Offer Documents For Previously Announced Friendly Acquisition
* AURORA CANNABIS AND CANNIMED THERAPEUTICS FILE OFFER DOCUMENTS FOR PREVIOUSLY ANNOUNCED FRIENDLY ACQUISITION Source text for Eikon: Further company coverage:
Jan 29 Canada's main stock index fell on Monday, touching a six-week low as energy and other resource shares tumbled alongside commodity prices.
Jan 24 Canada's No. 2 marijuana producer Aurora Cannabis Inc has agreed to buy smaller rival CanniMed Therapeutics Inc for C$1.1 billion ($852 million) as companies jostle to benefit from the country's legalization of recreational marijuana use later this year.
* AURORA CANNABIS AND CANNIMED THERAPEUTICS AGREE TO TERMS ON FRIENDLY TRANSACTION
Jan 24 Canadian marijuana producer Aurora Cannabis on Wednesday agreed to buy CanniMed Therapeutics Inc for about C$1.1 billion ($892.21 million), gearing up to meet an expected surge in demand at home and globally.
* CANNIMED THERAPEUTICS ANNOUNCES CONTINUED DISCUSSIONS WITH AURORA
TORONTO Canadian marijuana producer Aurora Cannabis Inc is in talks with rivals CanniMed Therapeutics Inc and Newstrike Resources Ltd to buy both businesses in a friendly deal that would create the nation's top weed company, people familiar with the matter told Reuters on Friday.